MFN Agreements, Heart Failure Evidence, and JCA Timelines

Episode 6 — 11 May 2026 Marcus and Sara examine the Trump administration's voluntary MFN pricing agreements with major pharma companies and discuss the HTA implications of WhiteSwell's DELTA-HF heart failure trial results. They debate the challenges of evidence strategy when major policy developments move at inconsistent paces. Hosted by Marcus and Sara. Outcomes Analytica Podcast — Daily briefings on HEOR, HTA strategy and the evidence access landscape. outcomes-analytica.no

Episode metadata supplied by the publisher feed · Published May 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

MFN Agreements, Heart Failure Evidence, and JCA Timelines

0:00 4:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Carl Haakon's Podcast?

This episode is 4 minutes long.

When was this Carl Haakon's Podcast episode published?

This episode was published on May 11, 2026.

Can I download this Carl Haakon's Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!